![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Prediction accuracy of the NASHmap algorithm designed to screen for presence of NASH
|
|
|
AASLD 2020 Nov 11-16
Reported by Jules Levin
Brenda Reinhart1, Matt Docherty2, Maria-Magdalena Balp3, Andreas Tietz3, Jennifer Cai4, Carolle Kinyua5, Marcos C Pedrosa3, Jörn M Schattenberg61ZS Associates, Zurich, Switzerland; 2ZS Associates, Philadelphia, PA, USA; 3Novartis Pharma AG, Basel, Switzerland; 4Novartis Pharmaceuticals Inc., East Hanover, USA; 5Novartis South Africa (Pty) Ltd, Waterfall City, South Africa; 6Department of Medicine, University Medical Center Mainz, Germany
![1201201](../images/120120/120120-1/1201201.gif)
![1201202](../images/120120/120120-1/1201202.gif)
![1201203](../images/120120/120120-1/1201203.gif)
![1201204](../images/120120/120120-1/1201204.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|